Device Trial Radar · NCT00903539
Prospective SecurAcath Subcutaneous Securement Trial
Last checked: Nov 20, 2026Latest source record: Jan 31, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Interrad MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To prospectively monitor the safety and performance of the catheter securement device in subjects whose catheter is secured with the Interrad Medical SecureAcath device.
Conditions
- Central Venous Catheter
Interventions
SecurAcath Securement SystemDevice
Subcutaneous catheter securement system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device Securement Success: defined as the percent of devices implanted and explanted without malfunction or device related complications attributed to the subcutaneous securement system.Time frame: Timeframe is the length of time the patient has the catheter in place. Can vary depending on the indication for the catheter (anywhere from 48 hours post-procedure to 6 months or more).
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
North Memorial Hospital - Minneapolis Radiology
Robbinsdale, Minnesota
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.